Semaglutide | 1/5 mg

What is Semaglutide?

Semaglutide is a medication used for the treatment of type 2 diabetes. It belongs to the incretin class and participates in the production of insulin by the pancreas, helps to reduce blood glucose levels, and promotes the acceleration of metabolism.

Semaglutide is a new generation medication that successfully controls blood sugar and normalises healthy weight. This peptide aids in the treatment of diabetes and also has a positive effect on the overall health condition of the body. The injectable medication Semaglutide can be combined with other diabetes treatments, supporting their action and having a positive impact on quality of life.

The positive effect of the use of the Semaglutide peptide is observed in the regulation of body weight, as it suppresses appetite, providing the body with a feeling of satiety. It improves blood pressure, blood cholesterol levels, which reduces the risk of developing heart diseases.

What are the benefits of Semaglutide?

Semaglutide is a medication that is an analog of the body's natural incretin hormones, which regulate blood glucose levels. It is used to treat type 2 diabetes, as well as to improve the general health condition of the body. The benefits of using the Semaglutide peptide include:

• Semaglutide helps to increase insulin production in the body and aids in controlling blood sugar levels.
• Semaglutide improves liver function, which reduces the risk of fat accumulation in it.
• This peptide plays a significant role in controlling sugar levels, reducing the risks of developing diabetic complications, kidney damage, and diabetic retinopathy.
• Semaglutide reduces appetite and signals satiety to the body, which supports healthy weight loss.
• It helps to improve the general health condition of the body and protects it from other diseases related to diabetes.
• The use of the Semaglutide peptide helps diabetics maintain control over blood glucose levels, reducing the risk of hypoglycemia.
• Semaglutide helps diabetics normalise their healthy weight, stimulating the feeling of satiety in the body.
• Semaglutide reduces blood glucose levels by stimulating insulin secretion by the pancreas.
• It can improve the lipid profile, reducing levels of "bad" LDL cholesterol and increasing "good" HDL cholesterol.
• It can help improve insulin sensitivity, which is particularly important for people with prediabetes or insulin resistance.
• Semaglutide is not a cure for type 2 diabetes, but a product that can be used as part of the overall treatment and contribute to the improvement of the general condition of the body in patients who lead a healthy and active lifestyle.

Clinical trials of Semaglutide and their results:

The Semaglutide medication has successfully passed all clinical trials, in which its high efficacy and safety in patients with type 2 diabetes were established.

In one of the large clinical trials SUSTAIN 6, which included 3,000 participants with diabetes, the results showed that the use of Semaglutide significantly reduces the risk of cardiac events and strokes in diabetics.

Other clinical trials have demonstrated the positive impact of the Semaglutide peptide in reducing blood glucose levels, stimulating the release of insulin by the pancreas, better glycemic control, and healthy weight regulation in participants.

The summarised results of all clinical trials indicate that the use of Semaglutide has a significant positive effect on the treatment of type 2 diabetes.

Correct Intake and Dosage of Semaglutide:

Semaglutide Dosage:

The dosage of Semaglutide depends on specific conditions, which is why consultation with a qualified specialist is recommended to determine the correct dose and method of administration.

Method of Administration:

Semaglutide is administered via subcutaneous injection once weekly. The initial dose is typically 0.25 mg, which may be increased to 0.5 mg or 1 mg, depending on individual needs. If a dose of Semaglutide is missed, it should be administered as soon as possible, but a double dose should never be taken.

Additional Instructions for Use:

• 1 unit corresponds to one increment marked on the pen dial (or the number displayed when the dose selector is turned).
• The injection should be performed in the abdominal area or the front of the thigh. After injecting the product, wait for 10 seconds before removing the needle. Rotating the injection site with each administration is recommended.

Information about the Pens:

A Semaglutide 5 mg pen contains 200 units of 25 mcg each.

• 1 unit = 25 mcg
• 10 units = 0.25 mg
• 20 units = 0.50 mg
• 30 units = 0.75 mg
• 40 units = 1 mg

A Semaglutide 1 mg pen contains 100 units of 10 mcg each.

• 1 unit = 10 mcg
• 10 units = 0.10 mg
• 20 units = 0.20 mg
• 25 units = 0.25 mg
• 50 units = 0.5 mg

Possible Side Effects of Semaglutide:

Semaglutide is a peptide used for the treatment of type 2 diabetes and, like any medication, its use can provoke adverse reactions. The occurrence of side effects is usually the result of incorrect administration of Semaglutide, being rare in patients who follow the prescribed dose.

The possible side effects after using Semaglutide manifest as headaches, nausea, diarrhoea, constipation, or slight itching on the skin around the injection site.

The listed possible side effects of using Semaglutide are not severe and generally disappear within a few days. Consulting a specialist is mandatory and following their instructions and dosages will prevent the occurrence of adverse reactions.

For research and laboratory use only. Not for human use.